Miniature Protein Scaffold Stabilizing PPII Helix Without Proline
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The technical challenge lies in designing miniature protein scaffolds that effectively modulate protein-protein interactions, as existing methods struggle to replicate the complex structures and interactions of native proteins, particularly the left-handed poly proline type-II helix, which is difficult to stabilize without proline residues.
Innovation Solution
A 19-residue mini-protein scaffold is designed with a novel topology featuring an extensive cation-π interaction network, comprising a β-strand:loop:PPII-helix structure, stabilized through interdigitated tertiary contacts, and incorporating D-Pro at position 9 to promote a β-hairpin, enhancing solubility and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a left-handed poly proline type-II helix is designed without proline residues, then the protein scaffold can be more versatile and easier to manufacture, but the stability and structural integrity of the helix becomes difficult to maintain
Solution Approach 1:
The patent changes the chemical parameters of the amino acid sequence by incorporating specific non-proline residues (such as arginine, lysine, and histidine) that can form alternative stabilizing interactions. This allows the PPII helix to maintain its left-handed conformation and structural integrity without relying on proline residues, thereby achieving both ease of manufacture and structural stability.
Solution Approach 2:
The patent creates a simplified copy of the proline-rich PPII helix structure using different amino acid building blocks. By copying the essential structural features and stabilizing interactions of natural PPII helices while substituting proline residues with alternative amino acids, the design achieves the desired helical structure without the manufacturing constraints associated with proline incorporation.
2Adaptability or versatility
If miniature protein scaffolds are designed to modulate protein-protein interactions, then their functional versatility increases, but the complexity of designing and stabilizing the required structures increases
Solution Approach 1:
The patent divides the miniature protein scaffold into distinct functional segments: a stable core structure (the PPII helix), interaction interfaces (surface-exposed residues), and flexible linkers. This segmentation allows independent optimization of each element - the core provides structural stability while the interfaces can be tailored for specific protein interaction targets, reducing overall design complexity.
Solution Approach 2:
The patent designs a universal PPII helix scaffold that can serve multiple functions by simply changing the surface-exposed amino acid residues. The core helical structure remains constant and provides stable binding, while the terminal residues can be customized to recognize different protein targets, enabling one scaffold design to modulate multiple different protein-protein interactions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mini-protein scaffold, TrpPlexus, exhibits thermostability and a well-folded tertiary structure, validated by CD spectroscopy and NMR, demonstrating a successful strategy for stabilizing a PPII-helix without proline residues, with potential applications in modulating protein interactions and as a biochemical tool.
Implementation Method 1
an extensive cation-π interaction network, as opposed to a binary isolated interaction
Implementation Method 2
a novel miniature protein topology composed of a β-strand:loop:PPII-helix, stabilized through interdigitated tertiary contacts
Implementation Method 3
incorporating D-Pro at position 9 to promote a β-hairpin
Data Source
AI summary
Miniature protein scaffolds and compositions thereof (e.g., vaccine formulations) and methods of using same are described herein. In a particular embodiment, the miniature protein scaffold comprises an isolated β-strand connected via a loop to a left-handed poly proline type-II (PPII) helix formed in the absence of proline residues.